Nice list! It did not include mitochondria dysfunction, but really you made your point.
However, who is going to test a patient to exclude all of that? One of our problems is that doctors don't have funds to test every CFS patient to exclude every possible condition, so they rely on clinical signs and symptoms. And that leads us to that enormous list because there are more diseases than symptoms. The body has a limited number of symptoms it can present, so symptoms overlap a lot.
The big problem I see with 'who to include' in a CFS study is not really which selection criteria to use, because any of them will pick up some CFS patients, along with many other problems. Rather the problem is that NONE of the selection criteria uses a concrete biomarker. They are still shooting in the dark.
I totally agree with this, and this discussion I think has become a little pointless, we are beating the proverbial dead horse (no animals were harmed to make this icon):
:deadhorse:
Everyone here I think agrees that
- some things are outdated and wrong in some of the CAA literature, and
- everything is wrong with the use of CBT/GET in the UK as sole treatments for ME, and
- something is wrong with CFS criterias used in studies, and
- something is wrong with one or more of the current XMRV studies.
One thought about the Oxford criteria, or any other really. Those are MINIMAL standards for diagnosis. So patients who meet Oxford may also be selected on stricter internal study criteria, but if all there is for CFS diagnosis at the time, or all that is accepted in the country of the study is Oxford, they have to say that. What I read in the Dutch study suggested that many of those patients probably would meet a stricter criteria. So just observing that a study has a weak criteria such as Oxford is not enough, you must also know exactly how those particular patients were selected, and what are their proven pathologies, whether they exceeded the criteria. And that is a problem right now in ALL of the XMRV studies, including WPI.
intertwining supposition,subjective terminology and opinion with some fact is not helpful in this arena.We are bedeviled enough by this approach allready.
Based on my obsevations of the posts and direct conversations with members of the forum the following is the majority opinion;
members suspect that there is something very wrong with the European studies carried out by a group of psychiatrists with a vested financial and egotistical interest in propagating their stance that ME/CFS is of psychological origin
They have also expressed the view that the use of CBT/GET as treatments are inappropiate anywhere in the world and potentially dangerous
The Oxford criterea are incapable of distinguishing patients with ME/CFS from those with clinical depression
The literature produced by the CAA regarding CBT and GET is wholly misleading and playing straight into the hands of the psychiatric lobby
Whether these expressed views generalise to other members is a question that,at the moment, no one can answer Perhaps other members could record their views on this thread?
The Oxford criterea are the diagnostic criterea used by this group of psychiatrists.
They are not the official guielines of the UK or anywhere else in the world.
If they are are adding in guesswork then that simply compounds the felony.
Being able to pick out some patients with CFS would be about as much use as a chocolate teapot in preparinga cohort for a trial.
Actively recruiting patients with depression would be somewhat problematic as well!
The method of selection of the patients in the European studies is perfectly clear.They used the diagnostic criterea established by Sharpe et al (1991) clearly stated in the studies.
By definition then they had no proven pathologies as they would be excluded.
In contrast the patients in the WPI cohort had an number of documented medical conditions so clearly a different cohort.
This folowing extract from your post is simply incorrect
"However, who is going to test a patient to exclude all of that? One of our problems is that doctors don't have funds to test every CFS patient to exclude every possible condition, so they rely on clinical signs and symptoms. And that leads us to that enormous list because there are more diseases than symptoms. The body has a limited number of symptoms it can present, so symptoms overlap a lot."
The reason they train doctors is to distiguish diseases whose "symptoms overlap a lot"
You dont need to" test a patient to exclude all that" merely the ones that have clinical conditions "at presentation or diagnosed subsequently" using a physical examination , history and signs(Sharpe et al 1991)
Ergo patients with known or" suspected" neuro immune or endocrine disorders are excluded simple enough